ATE439143T1 - Hm1.24 verwertende krebsvakzine - Google Patents
Hm1.24 verwertende krebsvakzineInfo
- Publication number
- ATE439143T1 ATE439143T1 AT03770047T AT03770047T ATE439143T1 AT E439143 T1 ATE439143 T1 AT E439143T1 AT 03770047 T AT03770047 T AT 03770047T AT 03770047 T AT03770047 T AT 03770047T AT E439143 T1 ATE439143 T1 AT E439143T1
- Authority
- AT
- Austria
- Prior art keywords
- cancer vaccine
- exploitable
- protein
- transduced
- antigen
- Prior art date
Links
- 229940022399 cancer vaccine Drugs 0.000 title abstract 2
- 238000009566 cancer vaccine Methods 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 210000004443 dendritic cell Anatomy 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/19—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/24—Antigen-presenting cells [APC]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
- A61K2239/57—Skin; melanoma
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002316639 | 2002-10-30 | ||
| PCT/JP2003/013954 WO2004039398A1 (en) | 2002-10-30 | 2003-10-30 | Hm1.24-utilizing cancer vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE439143T1 true ATE439143T1 (de) | 2009-08-15 |
Family
ID=32211691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03770047T ATE439143T1 (de) | 2002-10-30 | 2003-10-30 | Hm1.24 verwertende krebsvakzine |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8652839B2 (de) |
| EP (1) | EP1559432B1 (de) |
| JP (1) | JP4716730B2 (de) |
| AT (1) | ATE439143T1 (de) |
| AU (1) | AU2003278603A1 (de) |
| DE (1) | DE60328814D1 (de) |
| WO (1) | WO2004039398A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080219974A1 (en) * | 2002-03-01 | 2008-09-11 | Bernett Matthew J | Optimized antibodies that target hm1.24 |
| US8603481B2 (en) | 2003-10-10 | 2013-12-10 | Chugai Seiyaku Kabushiki Kaisha | Therapeutic agents for solid tumors |
| JP2006141208A (ja) * | 2004-11-16 | 2006-06-08 | Univ Of Tokushima | 多発性骨髄腫、白血病、悪性リンパ腫、肺癌等の免疫療法剤 |
| US8329186B2 (en) | 2004-12-20 | 2012-12-11 | Isu Abxis Co., Ltd | Treatment of inflammation using BST2 inhibitor |
| CA2660795C (en) | 2006-09-18 | 2014-11-18 | Xencor, Inc. | Optimized antibodies that target hm1.24 |
| EP2281579A1 (de) | 2009-08-05 | 2011-02-09 | BioNTech AG | Impfstoffzusammensetzung mit 5'-Cap-modifizierter RNA |
| CN107541513B (zh) * | 2016-06-28 | 2020-11-17 | 深圳宾德生物技术有限公司 | 用于沉默cd317的小分子干扰rna、重组载体、药物及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1059533A4 (de) * | 1998-02-25 | 2005-02-09 | Chugai Pharmaceutical Co Ltd | Methode zum immunologischen nachweis des anti-hm1.24 antikörpers |
| WO2001077362A1 (fr) * | 2000-04-06 | 2001-10-18 | Chugai Seiyaku Kabushiki Kaisha | Dosage immunologique d'anticorps anti hm1 . 24 |
| EP1352052B1 (de) * | 2001-01-15 | 2006-02-08 | I.D.M. Immuno-Designed Molecules | Verfahren zur herstellung von submikropartikel-suspensionen pharmazeutischer substanzen |
-
2003
- 2003-10-30 JP JP2004548092A patent/JP4716730B2/ja not_active Expired - Lifetime
- 2003-10-30 WO PCT/JP2003/013954 patent/WO2004039398A1/en active Application Filing
- 2003-10-30 DE DE60328814T patent/DE60328814D1/de not_active Expired - Lifetime
- 2003-10-30 EP EP03770047A patent/EP1559432B1/de not_active Expired - Lifetime
- 2003-10-30 AU AU2003278603A patent/AU2003278603A1/en not_active Abandoned
- 2003-10-30 US US10/533,104 patent/US8652839B2/en active Active
- 2003-10-30 AT AT03770047T patent/ATE439143T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006508094A (ja) | 2006-03-09 |
| EP1559432A1 (de) | 2005-08-03 |
| DE60328814D1 (de) | 2009-09-24 |
| AU2003278603A8 (en) | 2004-05-25 |
| WO2004039398A1 (en) | 2004-05-13 |
| US8652839B2 (en) | 2014-02-18 |
| EP1559432B1 (de) | 2009-08-12 |
| EP1559432A4 (de) | 2006-05-17 |
| AU2003278603A1 (en) | 2004-05-25 |
| US20060153883A1 (en) | 2006-07-13 |
| JP4716730B2 (ja) | 2011-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20020348L (no) | Peptid acceptor ligeringsmetoder | |
| CY1112735T1 (el) | Πολυπεπτιδια δυναμενα εκμαιευσης μιας ανοσιακης αντιδρασης εναντι του καρκινου | |
| WO2004024757A3 (en) | Modified pna molecules | |
| NO20042570L (no) | Antimikrobielle polypeptider fra Pseudoplectania nigrella | |
| EP1501863A4 (de) | Kinaseankerproteinmuteine, peptide davon und damit im zusammenhang stehende verfahren | |
| WO2005035003A3 (en) | Compositions and methods for increasing drug efficiency | |
| CY1105439T1 (el) | Κυτταρα, μεθοδοι καλλιεργειας και η χρηση τους στη θepαπεια με αυτολογη μεταμοσχευση | |
| DK1471926T3 (da) | Sammensætninger og fremgangsmåder til terapeutisk anvendelse af en atonal-associeret sekvens | |
| CY1116774T1 (el) | Συνθεση η οποια περιεχει lip2a leishmania | |
| EP1639127A4 (de) | Genetische typisierung auf dna-chip-basis | |
| DE60322613D1 (de) | Frostschutzproteine aus Basidiomyceten | |
| CY1109675T1 (el) | Αντιμικροβιακα πολυπεπτιδια | |
| ATE439143T1 (de) | Hm1.24 verwertende krebsvakzine | |
| ATE497506T1 (de) | Sars-verwandte proteine | |
| NO20073914L (no) | Biologisk aktive peptider | |
| CY1116649T1 (el) | Τεχνητη dna αλληλουχια με βελτιστοποιημενη λειτουργια οδηγου σε 5' (5-utr) για βελτιωμενη εκφραση ετερολογων πρωτεϊνων σε φυτα | |
| WO2005013904A3 (en) | Sars nucleic acids, proteins, vaccines, and uses thereof | |
| BR0316224A (pt) | Sequência de dna da região genÈmica tcd de photorhabdus luminescens | |
| BR0308659A (pt) | Proteìnas inseticidas do bacillus thuringiensis | |
| EP1364025A4 (de) | "neues, auf chromosom 16q24.3 kartiertes gen bno1" | |
| DE602004023311D1 (de) | Antigen-zufuhrsystem | |
| AU2003282465A8 (en) | Isolated mammalian membrane protein genes | |
| BR0303226A (pt) | Proteìnas de aderência e penetração de haemophilus | |
| ITTO20020969A1 (it) | Concentratore chimico per proteine. | |
| RU2006145775A (ru) | СТИМУЛЯТОР СИНТЕЗА БЕЛКА p55 ВИЧ-1 В КЛЕТКАХ ЭУКАРИОТ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |